# Andrew Berchuck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-berchuck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,597 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 114 |
| i10-index | 455 |
| Last Known Institution | Duke Medical Center |
| OpenAlex ID | https://openalex.org/A5038248146 |
| ORCID iD | https://orcid.org/0000-0002-1940-1467 |
| Works | 1,172 |

## Researcher papers

- [Integrated genomic analyses of ovarian carcinoma](https://scholariq.org/papers/integrated-genomic-analyses-of-ovarian-carcinoma/)
- [Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/ovarian-cancer-version-2-2020-nccn-clinical-practice-guidelines-in-oncology/)
- [NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022](https://scholariq.org/papers/nccn-guidelines-insights-ovarian-cancer-version-3-2022/)
- [The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers](https://scholariq.org/papers/the-oncoarray-consortium-a-network-for-understanding-the-genetic-architecture-of/)
- [A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24](https://scholariq.org/papers/a-genome-wide-association-study-identifies-susceptibility-loci-for-ovarian/)
- [ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer](https://scholariq.org/papers/abca-transporter-gene-expression-and-poor-outcome-in-epithelial-ovarian-cancer/)
- [Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions](https://scholariq.org/papers/preoperative-sensitivity-and-specificity-for-early-stage-ovarian-cancer-when/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [Duke Medical Center](https://scholariq.org/institutions/duke-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.